ECS Botanics Holdings Ltd (ASX: ECS)
Health Care · Pharmaceuticals · AU
AU$0.01
-9.09% today · -37.5% 1Y
ECS Botanics Holdings Ltd (ASX: ECS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.59M and employs 220 people.
Over the last twelve months the share price has lost 37.5%, trading between 0.00 and 0.01.
Tweenvest scores ECS Botanics Holdings Ltd across four factors: quality 54/100, value 70/100, growth 96/100. Its strongest factor is growth.
ECS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.59M
- Revenue (TTM)
- $14.54M
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 1.19
- 52-week high
- AU$0.01
- 52-week low
- AU$0.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.60B
- Employees
- 220
- Next earnings
- —
About ECS Botanics Holdings Ltd
ECS Botanics Holdings Ltd specializes in the cultivation, processing, and commercialization of medicinal cannabis products. The enterprise also markets a variety of hemp-derived wellness and food items and is active in the agricultural sector. Its primary operations are headquartered in Launceston, Australia.
- ISIN
- AU0000052490
- Founded
- 2018
- Listed since
- Jan 2, 2000
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Gelteq LimitedNasdaqCM: GELS | $5.83M | $0.52 | -0.02% |
| Firebrick Pharma LimitedASX: FRE | $5.81M | AU$0.03 | +3.57% |
| Panacea Life Sciences Holdings, Inc.OTCPK: PLSH | $5.78M | $0.09 | +6.25% |
| Invex Therapeutics LtdASX: IXC | $5.77M | AU$0.11 | -4.35% |
| Lamdong Pharmaceutical Joint Stock CompanyHNX: LDP | $5.50M | ₫7,600.00 | -1.30% |
| Lexaria Bioscience Corp.NasdaqCM: LEXX | $5.49M | $3.32 | +15.28% |
| Glow Lifetech Corp.CNSX: GLOW | $5.39M | CA$0.04 | -11.11% |
| Pulmatrix, Inc.NasdaqCM: PULM | $5.33M | $1.46 | -7.01% |
Figures last refreshed Oct 11, 2026.